Updated: Jul 22, 2024
The average Allogene Therapeutics stock price target is 9.51 with a max estimate of 13.00 and a min estimate of 4.60
Review Allogene Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Jul 22, 2024